WHITEHAWK THERAPEUTICS, INC. (WHWK) Current Ratio
- Current ratio · latest quarter: Value 17.38×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 17.38× | Current assets / current liabilities. $192.41M ÷ $11.07M ≈ 17.38× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 192.41M USD | Assets, Current |
| Current obligations | 11.07M USD | Liabilities, Current |
| Cash and equivalents | 85.23M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | Inventory, Net |
| Payables | 1.10M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $192.41M | $11.07M | $85.23M | (m) | (m) | (m) | $1.10M | (m) | 17.38× |
| 2026-03-31 | $125.55M | $11.06M | $34.79M | (m) | (m) | (m) | $1.75M | (m) | 11.36× |
| 2025-12-31 | $149.01M | $14.52M | $37.57M | (m) | (m) | (m) | $917.00K | (m) | 10.26× |
| 2025-09-30 | $165.04M | $9.85M | $37.93M | (m) | $0.00 | $0.00 | $1.63M | (m) | 16.76× |
| 2025-06-30 | $178.67M | $8.76M | $144.94M | (m) | $0.00 | $0.00 | $3.34M | (m) | 20.41× |
| 2025-03-31 | $232.61M | $12.27M | $227.57M | (m) | $0.00 | $0.00 | $3.66M | (m) | 18.95× |
| 2024-12-31 | $61.29M | $17.07M | $28.67M | (m) | $5.90M | $5.31M | $2.16M | (m) | 3.59× |
| 2024-09-30 | $77.31M | $15.81M | $30.54M | (m) | $6.54M | $5.47M | $1.37M | (m) | 4.89× |
| 2024-06-30 | $93.00M | $22.15M | $41.14M | (m) | $5.92M | $6.10M | $2.27M | (m) | 4.20× |
| 2024-03-31 | $102.57M | $19.88M | $53.78M | (m) | $4.93M | $5.94M | $3.10M | (m) | 5.16× |
| 2023-12-31 | $124.59M | $26.39M | $62.89M | (m) | $5.49M | $6.43M | $5.90M | (m) | 4.72× |
| 2023-09-30 | $132.88M | $20.52M | $68.80M | (m) | $5.72M | $3.62M | $2.60M | (m) | 6.48× |
| 2023-06-30 | $144.92M | $13.00M | $68.16M | (m) | $3.68M | $3.46M | $2.90M | (m) | 11.15× |
| 2023-03-31 | $164.93M | $17.75M | $34.05M | (m) | $5.57M | $3.80M | $6.51M | (m) | 9.29× |
| 2022-12-31 | $180.03M | $18.84M | $39.02M | (m) | $1.86M | $1.86M | $3.52M | (m) | 9.56× |
| 2022-09-30 | $189.86M | $17.89M | $134.81M | (m) | $2.26M | $734.00K | $3.92M | (m) | 10.61× |
| 2022-06-30 | $124.33M | $12.60M | $118.74M | (m) | $2.06M | $727.00K | $3.62M | (m) | 9.87× |
| 2022-03-31 | $135.62M | $11.51M | $129.85M | (m) | $2.71M | $202.00K | $4.01M | (m) | 11.78× |
| 2021-12-31 | $151.27M | $15.27M | $148.99M | (m) | $0.00 | $0.00 | $6.44M | (m) | 9.90× |
| 2021-09-30 | $162.02M | $11.57M | $161.38M | (m) | (m) | (m) | $5.21M | (m) | 14.01× |
| 2021-06-30 | $37.39M | $2.21M | $36.82M | (m) | (m) | (m) | $746.88K | (m) | 16.94× |
| 2021-03-31 | $41.00M | $2.13M | $39.01M | (m) | (m) | (m) | $458.66K | (m) | 19.26× |
| 2020-12-31 | $18.68M | $30.06M | $4.46M | (m) | $14.15M | (m) | $2.39M | (m) | 0.62× |
| 2020-09-30 | $49.58M | $2.51M | $47.28M | (m) | (m) | (m) | $709.27K | (m) | 19.74× |
| 2020-06-30 | $45.43M | $3.11M | $44.86M | (m) | (m) | (m) | $622.66K | (m) | 14.63× |
| 2020-03-31 | $35.39M | $2.65M | $34.58M | (m) | (m) | (m) | $421.12K | (m) | 13.33× |
| 2019-12-31 | $39.57M | $3.33M | $38.52M | (m) | (m) | (m) | $439.79K | (m) | 11.87× |
| 2019-09-30 | $44.80M | $3.60M | $43.39M | (m) | (m) | (m) | $750.99K | (m) | 12.44× |
| 2019-06-30 | $48.79M | $3.60M | $48.16M | (m) | (m) | (m) | $511.19K | (m) | 13.57× |
| 2019-03-31 | $54.30M | $3.92M | $53.42M | (m) | (m) | (m) | $1.06M | (m) | 13.84× |
| 2018-12-31 | $63.98M | $5.46M | $62.61M | (m) | (m) | (m) | $595.68K | (m) | 11.73× |
| 2018-09-30 | $70.04M | $3.64M | $68.81M | (m) | (m) | (m) | $717.00K | (m) | 19.22× |
| 2018-06-30 | $69.43M | $21.63M | $68.78M | (m) | (m) | (m) | $1.07M | (m) | 3.21× |
| 2018-03-31 | $14.61M | $3.62M | $13.76M | (m) | (m) | (m) | $1.63M | (m) | 4.03× |
| 2017-12-31 | $20.90M | $3.59M | $20.26M | (m) | (m) | (m) | $1.28M | (m) | 5.82× |
| 2017-09-30 | $25.86M | $2.59M | $24.83M | (m) | $39.25K | (m) | $855.42K | (m) | 10.00× |
| 2017-06-30 | $29.64M | $1.86M | $28.85M | (m) | $4.26K | (m) | $782.17K | (m) | 15.97× |
| 2017-03-31 | $36.12M | $2.97M | $35.14M | (m) | $32.45K | (m) | $1.87M | (m) | 12.16× |
| 2016-12-31 | $2.23M | $14.86M | $1.61M | (m) | $4.16K | (m) | $1.14M | (m) | 0.15× |
| 2013-03-31 | $3.83K | $105.44K | $2.71K | (m) | (m) | (m) | $6.38K | (m) | 0.04× |
| 2012-09-30 | $11.27K | $97.14K | $5.39K | (m) | (m) | (m) | $633.00 | (m) | 0.12× |
| 2012-06-30 | $15.56K | $95.40K | $9.31K | (m) | (m) | (m) | $175.00 | (m) | 0.16× |
| 2012-03-31 | $24.22K | $97.76K | $23.60K | (m) | (m) | (m) | $3.81K | (m) | 0.25× |
| 2011-12-31 | $6.63K | $74.80K | $4.13K | (m) | (m) | (m) | $2.98K | (m) | 0.09× |
| 2011-09-30 | $10.51K | $69.75K | $6.13K | (m) | (m) | (m) | $2.57K | (m) | 0.15× |
| 2011-06-30 | $15.48K | $68.39K | $9.23K | (m) | (m) | (m) | $2.20K | (m) | 0.23× |
| 2010-12-31 | $29.40K | $70.39K | $26.90K | (m) | (m) | (m) | $2.17K | (m) | 0.42× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |